Headquartered in West Lothian, Scotland, Bluestream Research & Development specialise in health sciences, engineering and technology sector projects and innovations.

Founded by Kenneth Redmond, Bluestream Research & Development was launched to offer innovation project support and the company is keen for other firms, including higher education institutions and those involved in Coronavirus (COVID-19) treatment and prevention, to consider business to university collaborations.

Delivering a dedicated research and development service with primary inclusion of three months initial design, Bluestream offers expert innovation and patent support, ensuring all projects and developments remain fully confidential.

Kenneth Redmond, Founder of Bluestream Research & Development, has also announced that they are in the process of researching and developing their own innovations across their specialised sectors.

Redmond commented: “We have a few patents to consider based on our engineering and health sciences experience and we are currently looking at developing a few projects, similar to our innovations, and deciding if they can be patented too.”

The initial project that Bluestream revealed they are exploring is to investigate altering cancer in the laboratory.

They state that their aim is to investigate the initial signs and symptoms of cancer and approach applications to similar laboratory ideas such as the USA chip for finding one cancer cell in a million.

Their second project in consideration is to investigate whether dementia can be altered or prevented with different intervention.

Commenting on the project, Redmond added: “Dementia alteration can be based on initial genes before they deteriorate and a lot of dementia conditions are covered under a similar umbrella – including frontal lobe dementia which is related to ten years previously suffering depression and others which are related to protein developments in the brain.”

Bluestream’s full list of development projects was revealed on their website in October 2020, with projects in cancer collapsing, embankment support and dementia alteration and prevention due to begin in August 2021.

For more information on Bluestream Research & Development, visit www.bluestreamresearch.org or contact kennyr@bluestreamresearch.org.